Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
Neuroscience News5h
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
Science Daily6h
Promising 'First' in Alzheimer's drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...
New study is a promising ‘first’ in Alzheimer’s drug development
Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...
Daijiworld11h
New Alzheimer’s drug shows promise to prevent buildup of tau proteins in brain cells
In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer’s drug that effectively prevents the build-up of Tau proteins -- a key driver ...
Breakthrough Alzheimer’s drug successfully blocks both major disease ‘hotspots’ at once for the first time
RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...
technologynetworks9h
Promising Breakthrough in Alzheimer's Drug Development
For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the Tau protein - addressing a critical gap in current treatments.